MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 64 filers reported holding MEREO BIOPHARMA GROUP PLC in Q3 2021. The put-call ratio across all filers is 1.46 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $191,281 | -36.3% | 591,676 | -33.6% | 0.02% | -52.1% |
Q2 2023 | $300,235 | +50.9% | 891,676 | +44.8% | 0.05% | +33.3% |
Q2 2022 | $199,000 | -37.4% | 615,856 | -32.8% | 0.04% | -14.3% |
Q1 2022 | $318,000 | +3.6% | 915,856 | +7.3% | 0.04% | -8.7% |
Q4 2021 | $307,000 | -4.7% | 853,680 | -5.5% | 0.05% | +100.0% |
Q3 2021 | $322,000 | -6.9% | 903,680 | -4.3% | 0.02% | -17.9% |
Q2 2021 | $346,000 | -17.4% | 944,308 | -17.6% | 0.03% | +100.0% |
Q1 2021 | $419,000 | +0.7% | 1,146,308 | 0.0% | 0.01% | -22.2% |
Q4 2020 | $416,000 | -39.5% | 1,146,308 | -4.2% | 0.02% | -64.0% |
Q3 2020 | $688,000 | – | 1,196,308 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vivo Capital, LLC | 6,220,938 | $16,299,000 | 0.94% |
Boxer Capital, LLC | 4,029,649 | $10,558,000 | 0.36% |
DAFNA Capital Management LLC | 199,425 | $522,000 | 0.17% |
J. Goldman & Co LP | 443,517 | $1,162,000 | 0.08% |
Ikarian Capital, LLC | 1,196,308 | $688,000 | 0.05% |
HHLR ADVISORS, LTD. | 1,598,185 | $4,187,000 | 0.03% |
BOOTHBAY FUND MANAGEMENT, LLC | 133,634 | $350,000 | 0.02% |
F3Logic, LLC | 255 | $668,000 | 0.02% |
Schonfeld Strategic Advisors LLC | 343,195 | $899,000 | 0.02% |
CSS LLC/IL | 54,773 | $144,000 | 0.01% |